CDT Equity Inc, Stock Price, News & Analysis
Company Description
CDT Equity Inc, (NASDAQ: CDTTW) is a publicly traded company in the Pharmaceutical Preparations sector.
CDTTW stock has gained 2.0% over the past year. Shares last traded at $0.0100.
On a trailing twelve-month basis, CDT Equity Inc, and diluted earnings per share of $-1177.89.
This page provides a comprehensive overview of CDTTW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CDT Equity Inc, (CDTTW) stock last traded at $0.0100. Over the past 12 months, the stock has gained 2.0%.
Latest News
SEC Filings
CDT Equity Inc, has filed 10 recent SEC filings, including 4 Form SCHEDULE 13G, 4 Form 8-K, 2 Form NT 10-Q. The most recent filing was submitted on June 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CDTTW SEC filings →
Financial Highlights
Diluted earnings per share stood at $-1177.89. The company generated -$15.6M in operating cash flow. With a current ratio of 0.34, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in CDT Equity Inc, (CDTTW) currently stands at 38.0 thousand shares, down 4.3% from the previous reporting period, representing 1.7% of the float. Over the past 12 months, short interest has increased by 2522.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for CDT Equity Inc, (CDTTW) currently stands at 3.8 days, up 43.2% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 278% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 14.0 days.
CDTTW Company Profile & Sector Positioning
CDT Equity Inc, (CDTTW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.